Search

everythinglearnresearchcommunity

for

Search:↓

The dense fine speckled pattern in ANA tests is common in autoimmune diseases, challenging previous beliefs that it was unrelated.

Stress, nutritional issues, and chronic diseases can cause hair loss, and nail changes may signal internal diseases; treatment focuses on the underlying cause.

Tyrosine kinase inhibitors show promise in treating some skin diseases but their definitive role in dermatology is still unclear.

Azathioprine's effectiveness and safety require careful monitoring and more research, especially regarding its use with corticosteroids and the role of TPMT status in patients.

People with HIV and low T cell counts have more hair and scalp problems.

Tacrolimus solution is effective and well-tolerated for treating inflammatory scalp conditions.

The most common cause of hair loss in children is tinea capitis, followed by alopecia areata and telogen effluvium.

Treating skin conditions with both psychological and dermatological care improves patient outcomes and can save costs.

Some medications can improve skin conditions, while lifestyle factors like smoking and drinking may worsen them; treatments like monoclonal antibodies and imiquimod cream show promise for certain skin diseases.

Immunosuppressive and anti-TNF therapies in IBD patients can increase the risk of skin cancer and cause various skin issues.

Ultraviolet rays damage hair, smoking may cause hair loss, and good nutrition is important for hair health, but genetics mainly decide hair thickness.

Trichoscopy is a useful tool for diagnosing and managing hair and scalp conditions, often better than traditional methods.

Skin aging reflects overall body aging and can indicate internal health conditions.

Some treatments work better for different types of hair loss, and nutrients like iron and L-lysine are important for preventing hair loss.

Mycophenolate mofetil may improve lupus nephritis remission more than cyclophosphamide but with uncertain safety.

Oxidative stress plays a significant role in alopecia areata, and new treatments may include JAK inhibitors and antioxidants.

Antituberculous drugs improved symptoms in a woman with lupus and myositis.

New treatments for alopecia areata show promise, but standardized guidelines are needed.

Up to 50% of women may experience significant hair loss by age 50, with various causes and treatments available.

Hair loss that spreads out can often fix itself or be treated by finding and handling the cause.

The document provided instructions for completing a CME exam on diagnosing and managing hair loss.

The document concluded that more research is needed to find the best treatment for Frontal fibrosing alopecia.

Cardiovascular drugs can cause various skin problems, so recognizing these reactions is important.

The document is a detailed guide on skin conditions and treatments for dermatologists.

The document concludes that hair loss in women is complex, often linked to aging, health conditions, and nutritional deficiencies, and emotional impacts should not be underestimated.

The document lists various dermatology topics, treatments, and diagnostic methods.

β-blockers can cause skin problems like psoriasis and vitiligo, and doctors should tell patients about these risks.

New targeted cancer drugs can cause skin side effects, and managing them requires patient education and timely care.

Most skin rashes in rheumatoid arthritis patients were not caused by their medication, and careful evaluation allowed most to keep taking their beneficial treatment.

Hormonal imbalances during menopause may significantly contribute to Frontal Fibrosing Alopecia.